跳至主要内容
临床试验/NCT00927654
NCT00927654已完成3 期

Effect of Iloprost Inhalation Before and During Extracorporeal Circulation (ECC) on Perioperative Morbidity and Outcome in High Risk Cardiac Surgical Patients

Ludwig-Maximilians - University of Munich6 个研究点 分布在 1 个国家目标入组 253 人开始时间: 2009年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
253
试验地点
6
主要终点
Duration of post-operative artificial respiration after arrival on intensive care unit

研究概览

简要总结

In this study effects of the intra operative, prophylactic inhalation of Iloprost (Ventavis) before and during extracorporal circulation on perioperative morbidity and outcome in high risk cardiac surgical patients is investigated in comparison to placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • written informed consent
  • for females of childbearing potential: negative pregnancy test
  • patients, male or female, 18 to 85 years old
  • elective open-heart surgery using heart-lung-machine
  • patients with increased risk to suffer from perioperative right heart failure, i.e.,
  • protracted surgery: multiple valvular transplant or expected bypass time exceeding 120 min and/or
  • patients with preoperative known pulmonary hypertension and/or
  • patients with severe heart insufficiency (NYHA III or NYHA IV)

排除标准

  • patient not able to give consent
  • pregnant or nursing patients
  • Anamnestic known hypersensitivity to the used drug (Ventavis) and its ingredients or to drugs with a similar chemical structure
  • blood clotting disorder requiring treatment
  • trauma, intracerebral bleeding or apoplexy within the last 3 months prior to surgery
  • primary or secondary immune deficiency (e.g., pretreatment with steroids, cytostatics)
  • systemic infection
  • lung disorder with impaired gas exchange
  • lung transplantation
  • cardiac transplantation
  • implantation of LVAD (left ventricular assist device)
  • fluoride ulcus disorder
  • planned surgery in deep hypothermia and cardiac arrest
  • subconscious and psychiatric disordered patients
  • participation in another clinical trial within the last 30 days prior to study start and up to 30 days after end of study
  • previous participation in this study

研究组 & 干预措施

Iloprost

Experimental

干预措施: Iloprost (Ventavis) (Drug)

Isotonic Sodium Chloride solution 0.9 %

Placebo Comparator

干预措施: Isotonic Sodium Chloride solution 0.9 % (placebo) (Drug)

结局指标

主要结局

Duration of post-operative artificial respiration after arrival on intensive care unit

时间窗: 2-3 months

次要结局

  • 90 days lethality(90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. med. B. Zwissler

Director Clinic for Anesthesiology

Ludwig-Maximilians - University of Munich

研究点 (6)

Loading locations...

相似试验

Iloprost in High Risk Cardiac Surgical Patients | 临床试验